CXCL12 and ovarian cancer: Nataša and group found that the tumor-associated inflammatory mediator prostaglandin E2 (PGE2) regulated CXCL12 production in malignant ascites of ovarian cancer patients, as well as CXCR4 expression on MDSC and its response to CXCL12.